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1. INTRODUCTION {#hed26292-sec-0005}
===============

The COVID‐19 pandemic has presented health care providers with a unique set of challenges. While all health care providers have some exposure risk, it is particularly pronounced in those caring for patients undergoing mucosal or aerosol‐generating procedures.[^1^](#hed26292-bib-0001){ref-type="ref"}, [^2^](#hed26292-bib-0002){ref-type="ref"}, [^3^](#hed26292-bib-0003){ref-type="ref"} At baseline, there are increased risks of acute respiratory infections among health care workers during procedures such as tracheal intubation, tracheotomy, noninvasive ventilation, and manual ventilation.[^4^](#hed26292-bib-0004){ref-type="ref"} Anecdotal reports from Wuhan, China report higher rates of COVID‐19 infection specifically among otolaryngologists, likely due to the frequent use of those high‐risk procedures in their typical, often nonelective, practice.[^5^](#hed26292-bib-0005){ref-type="ref"}, [^6^](#hed26292-bib-0006){ref-type="ref"}, [^7^](#hed26292-bib-0007){ref-type="ref"}, [^8^](#hed26292-bib-0008){ref-type="ref"}, [^9^](#hed26292-bib-0009){ref-type="ref"} This risk of exposure can be mitigated through the use of personal protective equipment (PPE); however, this essential resource is already becoming scarce.[^10^](#hed26292-bib-0010){ref-type="ref"} In addition, they are being faced with increasing numbers of positive cases, unfamiliar hospital roles, and concern for safety of themselves, their loved ones, and their patients. Thus, beyond the risk to their physical health, there is also great risk to their mental well‐being.

A review of prior outbreaks demonstrates a history of a mental burden on health care providers during similar times. A number of studies conducted during the 2003 severe acute respiratory syndrome (SARS) and 2014 Ebola crises used surveys and in‐depth interviews to demonstrate increased symptoms of stress, anxiety, depression, insomnia, and distress among health care workers.[^11^](#hed26292-bib-0011){ref-type="ref"}, [^12^](#hed26292-bib-0012){ref-type="ref"}, [^13^](#hed26292-bib-0013){ref-type="ref"}, [^14^](#hed26292-bib-0014){ref-type="ref"}, [^15^](#hed26292-bib-0015){ref-type="ref"}, [^16^](#hed26292-bib-0016){ref-type="ref"}, [^17^](#hed26292-bib-0017){ref-type="ref"} In certain situations, investigators still found increased psychiatric morbidity 1 to 2 years after the 2003 SARS outbreak, though it is unclear whether these can be directly attributable to SARS.[^18^](#hed26292-bib-0018){ref-type="ref"}, [^19^](#hed26292-bib-0019){ref-type="ref"}, [^20^](#hed26292-bib-0020){ref-type="ref"} There are now similar concerns for the health care workers during the COVID‐19 pandemic. Studies from COVID‐19 in Wuhan, China, where it was first detected, as well as in Singapore and India have already shown an increased mental strain on health care workers, reflected through validated surveys on anxiety, depression, insomnia, and distress.[^21^](#hed26292-bib-0021){ref-type="ref"}, [^22^](#hed26292-bib-0022){ref-type="ref"}, [^23^](#hed26292-bib-0023){ref-type="ref"} This collection of prior evidence suggests a need to provide early support and intervention in the hopes of preventing any immediate or long‐lasting implications.

Despite the history of increased psychiatric symptoms in health care workers during outbreaks and the increased infection risk among providers exposed to aerosolization, to the best of our knowledge, no study has characterized the impact on the mental health of this specific population. This study aims to assess mental health symptoms among otolaryngology physicians during the COVID‐19 pandemic by measuring symptoms of burnout, anxiety, depression, and distress.

2. PATIENTS AND METHODS {#hed26292-sec-0006}
=======================

This is a cross‐sectional, survey‐based, national study conducted during the COVID‐19 pandemic from April 14, 2020 to April 25, 2020. The self‐administered, anonymous online survey collected demographic data and mental health measurements from otolaryngology physicians from academic institutions throughout the United States. Participation was voluntary, and participants were allowed to terminate the survey at any time. A Research Electronic Data Capture database was developed specifically for this project and used to capture survey data. It was accessible only to study personnel. This project was reviewed and determined to qualify as quality improvement by the University of Pennsylvania\'s Institutional Review Board.

We contacted otolaryngology program directors via e‐mail from all 109 allopathic academic programs in the United States to disperse the survey to their residents, fellows, and attendings. Demographic data were self‐reported by the participants, including sex (male or female), age, occupation (attending physicians, fellows, resident physicians), and geographic location. Date of projected peak resource utilization for each state was obtained from the Institute for Health Metrics and Evaluation\'s *COVID‐19 Projections* in order to categorize participants based on the "Surge status" of their state.[^24^](#hed26292-bib-0024){ref-type="ref"} States reaching their date of projected peak resource use during our study period were in the "Surge," while states that had not reached that date were "Pre Surge," and states that were already past that date were "Post Surge." Numbers of positive COVID‐19 cases and numbers of COVID‐19 deaths per state were obtained from the *COVID Tracking Project* from date April 19, 2020, the midpoint of our study period.[^25^](#hed26292-bib-0025){ref-type="ref"}

We focused on symptoms of burnout, anxiety, distress, and depression for all participants, using validated measurement tools.[^26^](#hed26292-bib-0026){ref-type="ref"}, [^27^](#hed26292-bib-0027){ref-type="ref"}, [^28^](#hed26292-bib-0028){ref-type="ref"}, [^29^](#hed26292-bib-0029){ref-type="ref"}, [^30^](#hed26292-bib-0030){ref-type="ref"} The single‐item Mini‐Z Burnout Assessment (range, 1‐5) was used to assess burnout, with burnout defined as ≥3.[^27^](#hed26292-bib-0027){ref-type="ref"}, [^28^](#hed26292-bib-0028){ref-type="ref"} The 7‐item Generalized Anxiety Disorder (GAD‐7) Scale (range, 0‐21) was used to assess symptoms of anxiety over the past 2 weeks, with a scale of normal (0‐4), mild (5‐9), moderate (10‐14), and severe (15‐21) anxiety.[^26^](#hed26292-bib-0026){ref-type="ref"} A score of 10 has been reported to be a cutoff point for identifying cases of GAD. The GAD‐7 included a final question assessing the "difficulty (these problems) made it for you to do your work, take care of things at home, or get along with other people" (range, 0‐3). The 15‐item Impact of Event Scale (IES; range, 0‐75) was used to assess symptoms of distress over the past 7 days, with a scale of subclinical (0‐8), mild (9‐25), moderate (26‐43), and severe (44‐75) distress.[^29^](#hed26292-bib-0029){ref-type="ref"} A score of 27 has been reported as a cutoff for risk of post‐traumatic stress disorder (PTSD).[^31^](#hed26292-bib-0031){ref-type="ref"} The IES total score was also divided into two subscores: intrusion (range, 0‐35) and avoidance (range, 0‐40). Per Horowitz et al, the intrusion subscores assessed symptoms of "unbidden thoughts and images, troubled dreams, strong pangs or waves of feelings, and repetitive behavior."[^29^](#hed26292-bib-0029){ref-type="ref"} The avoidance subscore measured "ideational constriction, behavioral inhibition and counterphobic activity, and awareness of emotional numbness."[^29^](#hed26292-bib-0029){ref-type="ref"} The 2‐item Patient Health Questionnaire (PHQ‐2; range, 0‐6) was used to assess symptoms of depression over the past 2 weeks, with a score of 3 as the cutoff for a positive depression screening requiring further evaluation with the more in‐depth PHQ‐9.[^30^](#hed26292-bib-0030){ref-type="ref"} These categories were based on values established in the literature.[^26^](#hed26292-bib-0026){ref-type="ref"}, [^27^](#hed26292-bib-0027){ref-type="ref"}, [^28^](#hed26292-bib-0028){ref-type="ref"}, [^29^](#hed26292-bib-0029){ref-type="ref"}, [^30^](#hed26292-bib-0030){ref-type="ref"}

Data analysis was performed using R software version 3.6.3. The difference in distribution of symptoms across multiple groups is tested by the chi‐square independence test (Tables 2 and 3) and by the nonparametric Wilcoxon rank sum test and Kruskal‐Wallis test (Tables 4 and 5). To determine risk factors for severity of burnout, anxiety, distress, and depression, multiple logistic regression models were used (Table 6). The binary outcome variables were created for anxiety (normal vs other categories) and for distress (subclinical vs other categories). Type of physician, sex, age, surge status, and number of positive cases were included in the model, while location and number of deaths were found to be highly correlated with the number of positive cases and therefore excluded to alleviate the issue of collinearity. All tests were two‐sided and the significance level *α* = .05 was applied. 95% Confidence intervals (CIs) were constructed, where applicable.

3. RESULTS {#hed26292-sec-0007}
==========

3.1. Baseline characteristics {#hed26292-sec-0008}
-----------------------------

A total of 349 physicians completed the survey. Of these, 165 (47.3%) were residents, and 184 (52.7%) were attending physicians, of which 12 were fellows. A number of 1614 otolaryngology residents and 2849 otolaryngology fellows and attendings work at the academic institutions contacted based on review of each institution\'s website. Thus, our response rate is 10.22% for residents and 6.46% for attendings, though these may be underestimates as we do not know whether all programs ultimately dispersed the survey to their physicians. Table [1](#hed26292-tbl-0001){ref-type="table"} lists the demographic variables for the entire population. Most participants were men (212 \[60.7%\]), and the most common age range was 31‐35 years (114 \[32.7%\]). Our male to female breakdown is consistent with that of the otolaryngology population, where 63.9% of residents and 85% of attendings are estimated to be males.[^32^](#hed26292-bib-0032){ref-type="ref"}, [^33^](#hed26292-bib-0033){ref-type="ref"} A number of 126 (36.1%) participants worked in the Midwest, 107 (30.7%) worked in the Northeast, 75 (21.5%) in the South, and 41 (11.7%) in the West. The majority came from states projected to reach their peak resource use during the study period (205 \[58.7%\]). Following, 54.2% of participants came from states estimated to have greater than 20 000 confirmed positive COVID‐19 cases, and 54.2% came from states estimated to have greater than 1000 COVID‐19 deaths.

###### 

Demographic characteristics of the study population

                         Role, N (%)   Location, N (%)   Surge, N (%)   Cases, N (%)   Deaths, N (%)                                                                                            
  --------- ------------ ------------- ----------------- -------------- -------------- --------------- ----------- ----------- ------------ ------------ ------------ ------------ ------------ ------------
  Overall   349 (100)    165 (47.3)    184 (52.7)        126 (36.1)     107 (30.7)     75 (21.5)       41 (11.7)   28 (8.0)    205 (58.7)   116 (33.2)   189 (54.2)   160 (45.8)   189 (54.2)   160 (45.8)
  Sex                                                                                                                                                                                           
  Men       212 (60.7)   89 (53.9)     123 (66.8)        75 (59.5)      64 (59.8)      47 (62.7)       26 (63.4)   19 (67.9)   126 (61.5)   67 (57.8)    116 (61.4)   96 (60.0)    116 (61.4)   96 (60.0)
  Women     137 (39.3)   76 (46.1)     61 (33.2)         51 (40.5)      43 (40.2)      28 (37.3)       15 (36.6)   9 (32.1)    79 (38.5)    49 (42.2)    73 (38.6)    64 (40.0)    73 (38.6)    64 (40.0)
  Age                                                                                                                                                                                           
  26‐30     94 (26.9)    93 (56.4)     1 (0.5)           35 (27.8)      32 (29.9)      20 (26.7)       7 (17.1)    4 (14.3)    53 (25.9)    37 (31.9)    40 (21.2)    54 (33.8)    45 (23.8)    49 (30.6)
  31‐35     114 (32.7)   66 (40.0)     48 (26.1)         42 (33.3)      31 (29.0)      25 (33.3)       16 (39.0)   15 (53.6)   62 (30.2)    37 (31.9)    69 (36.5)    45 (28.1)    65 (34.4)    49 (30.6)
  36‐40     44 (12.6)    3 (1.8)       41 (22.3)         18 (14.3)      12 (11.2)      8 (10.7)        6 (14.6)    2 (7.1)     32 (15.6)    10 (8.6)     25 (13.2)    19 (11.9)    24 (12.7)    20 (12.5)
  \>40      97 (27.8)    3 (1.8)       94 (51.1)         31 (24.6)      32 (29.9)      22 (29.3)       12 (29.3)   7 (25.0)    58 (28.3)    32 (27.6)    55 (29.1)    42 (26.2)    55 (29.1)    42 (26.2)

3.2. Mini‐Z Burnout Scale scores {#hed26292-sec-0009}
--------------------------------

Burnout was reported in 76 (21.8%) of participants. A greater distribution of resident physicians were experiencing burnout compared to attending physicians (49 \[29.7%\] vs 27 \[14.7%\]; *P* = .001). A significantly greater proportion of female physicians also reported burnout compared to male physicians (40 \[29.2%\] vs 36 \[17.0%\]; *P* = .010) (Table [2](#hed26292-tbl-0002){ref-type="table"}). The median (interquartile range, IQR) scores on the Mini‐Z Burnout measurement for all participants was 2.0 (2.0‐2.0). As with the results grouped by the cutoff point, analysis of the median scores found residents to have a significantly increased score for burnout compared to attendings (2.0 \[2.0‐3.0\] vs 2.0 \[2.0‐2.0\]; *P* \< .0005), and females to have a significantly increased scores for burnout compared to males (2.0 \[2.0‐3.0\] vs 2.0 \[2.0‐2.0\]; *P* = .004) (Table 4). Multivariable logistic regression analysis, which controlled for confounders, also showed that attendings were less likely to have positive screening for burnout compared to residents (odds ratio \[OR\] 0.28, CI \[0.11‐0.68\]; *P* = .005). In addition, compared to male physicians, females physicians were more likely have a positive screening for burnout (OR 1.93, CI \[1.12.‐3.32\]; *P* = .018) (Table 6).

###### 

Symptom severity of burnout, anxiety, distress, and depression measurements in total cohort and subgroups (role, sex, and age)

                                                 Role, N (%)   Sex, N (%)   Age, N (%)                                                                                          
  ------------------------------- -------------- ------------- ------------ ------------ ------------ ------------ ----------- ----------- ------------ ----------- ----------- -----------
  Severity category               Total, N (%)   Resident      Attending    *P* value    Men          Women        *P* value   26‐30       31‐35        36‐40       \>40        *P* value
  Mini‐Z: burnout symptoms                                                                                                                                                      
  Negative                        273 (78.2)     116 (70.3)    157 (85.3)   **.001**     176 (83.0)   97 (70.8)    **.010**    67 (71.3)   89 (78.1)    34 (77.3)   83 (85.6)   .124
  Positive                        76 (21.8)      49 (29.7)     27 (14.7)                 36 (17.0)    40 (29.2)                27 (28.7)   25 (21.9)    10 (22.7)   14 (14.4)   
  GAD‐7: anxiety symptoms                                                                                                                                                       
  Normal                          182 (52.1)     82 (49.7)     100 (54.3)   .280         129 (60.8)   53 (38.7)    **.001**    42 (44.7)   63 (55.3)    23 (52.3)   54 (55.7)   .190
  Mild                            101 (28.9)     49 (29.7)     52 (28.3)                 49 (23.1)    52 (38.0)                32 (34.0)   30 (26.3)    13 (29.5)   26 (26.8)   
  Moderate                        40 (11.5)      24 (14.5)     16 (8.7)                  21 (9.9)     19 (13.9)                14 (14.9)   15 (13.2)    1 (2.3)     10 (10.3)   
  Severe                          26 (7.4)       10 (6.1)      16 (8.7)                  13 (6.1)     13 (9.5)                 6 (6.4)     6 (5.3)      7 (15.9)    7 (7.2)     
  GAD‐7: difficulty functioning                                                                                                                                                 
  Not difficult                   163 (46.7)     79 (47.9)     84 (45.7)    .293         113 (53.3)   50 (36.5)    **.011**    42 (44.7)   57 (50.0)    17 (38.6)   47 (48.5)   .190
  Somewhat difficult              168 (48.1)     76 (46.1)     92 (50.0)                 88 (41.5)    80 (58.4)                45 (47.9)   54 (47.4)    23 (52.3)   46 (47.4)   
  Very difficult                  15 (4.3)       7 (4.2)       8 (4.3)                   10 (4.7)     5 (3.6)                  4 (4.3)     3 (2.6)      4 (9.1)     4 (4.1)     
  Extremely difficult             3 (0.9)        3 (1.8)       0 (0.0)                   1 (0.5)      2 (1.5)                  3 (3.2)     0 (0.0)      0 (0.0)     0 (0.0)     
  IES: distress symptoms                                                                                                                                                        
  Subclinical                     139 (39.8)     69 (41.8)     70 (38.0)    .358         100 (47.2)   39 (28.5)    **.001**    38 (40.4)   49 (43.0)    19 (43.2)   33 (34.0)   .433
  Mild                            114 (32.7)     47 (28.5)     67 (36.4)                 67 (31.6)    47 (34.3)                26 (27.7)   36 (31.6)    13 (29.5)   39 (40.2)   
  Moderate                        73 (20.9)      39 (23.6)     34 (18.5)                 32 (15.1)    41 (29.9)                22 (23.4)   26 (22.8)    8 (18.2)    17 (17.5)   
  Severe                          23 (6.6)       10 (6.1)      13 (7.1)                  13 (6.1)     10 (7.3)                 8 (8.5)     3 (2.6)      4 (9.1)     8 (8.2)     
  PHQ‐2: depression symptoms                                                                                                                                                    
  Negative                        312 (89.4)     148 (89.7)    164 (89.1)   1.000        189 (89.2)   123 (89.8)   .993        83 (88.3)   107 (93.9)   37 (84.1)   85 (87.6)   .247
  Positive                        37 (10.6)      17 (10.3)     20 (10.9)                 23 (10.8)    14 (10.2)                11 (11.7)   7 (6.1)      7 (15.9)    12 (12.4)   

*Note*: All statistically significant values are marked in bold.

Abbreviations: GAD‐7, 7‐item Generalized Anxiety Disorder Scale; IES, Impact of Event Scale; PHQ‐2, two‐item Patient Health Questionnaire.

3.3. GAD‐7 Anxiety Scale scores {#hed26292-sec-0010}
-------------------------------

A large portion of participants had symptoms of anxiety (167 \[47.9%\]), with 28.9% of all participants in the mild range, 11.5% in the moderate range, and 7.4% in the severe range. For the question at the end of the GAD‐7 asking "How difficult have these (symptoms) made it for you to do your work, take care of things at home, or get along with other people?" 48.1% of participants reported "somewhat difficult," 4.3% reported "very difficult," and 0.9% reported "extremely difficult." Females reported increased symptoms of anxiety (*P* = .001) and increased difficulty with the getting work done, tasks at home, or getting along with other people (*P* = .011) (Table [2](#hed26292-tbl-0002){ref-type="table"}). The median (IQR) score on the GAD‐7 was 4.0 (2.0‐8.0). Similar to findings in severity of symptoms, female participants had higher scores compared to males (6.0 \[3.0‐9.0\] vs 3.0 \[1.8‐7.0\]; *P* \< .0005) (Table 4). Multivariable logistic regression analysis also showed that females were more likely to report anxiety (OR 2.53, CI \[1.59‐4.02\]; *P* \< .005) (Table 6).

3.4. IES Distress Scale scores {#hed26292-sec-0011}
------------------------------

A large portion of participants had symptoms of distress (210 \[60.2%\]), with 32.7% of all participants in the mild range, 20.9% in the moderate range, and 6.6% in the severe range. Females reported experiencing higher symptoms of distress compared to males (*P* = .001, Table [2](#hed26292-tbl-0002){ref-type="table"}). Compared with those working in states with less than 20 000 positive cases, participants working in states with greater than 20 000 positive cases were significantly more likely to experience symptoms of distress on the IES (*P* = .027). Compared to those working in states with less than 1000 deaths reported, participants working in states with greater than 1000 reported deaths were also significantly more likely to experience symptoms of distress on the IES (*P* = .013) (Table [3](#hed26292-tbl-0003){ref-type="table"}).

###### 

Symptom severity of burnout, anxiety, distress, and depression measurements in total cohort and subgroups (location, surge status, state COVID‐19‐positive case numbers, and state COVID‐19 deaths)

                                                 Location, N (%)   Surge, N (%)   Cases, N (%)   Deaths, N (%)                                                                                                                                 
  ------------------------------- -------------- ----------------- -------------- -------------- --------------- ----------- ----------- ------------ ------------ ----------- ------------ ------------ ----------- ------------ ------------ -----------
  Severity category               Total, N (%)   Midwest           Northeast      South          West            *P* value   Pre         Surge        Post         *P* value   \<20 000     \>20 000     *P* value   \<1000       \>1000       *P* value
  Mini‐Z: burnout symptoms                                                                                                                                                                                                                     
  Negative                        273 (78.2)     95 (75.4)         84 (78.5)      63 (84.0)      31 (75.6)       .526        22 (78.6)   161 (78.5)   90 (77.6)    .979        153 (81.0)   120 (75.0)   .225        153 (81.0)   120 (75.0)   .225
  Positive                        76 (21.8)      31 (24.6)         23 (21.5)      12 (16.0)      10 (24.4)                   6 (21.4)    44 (21.5)    26 (22.4)                36 (19.0)    40 (25.0)                36 (19.0)    40 (25.0)    
  GAD‐7: anxiety symptoms                                                                                                                                                                                                                      
  Normal                          182 (52.1)     69 (54.8)         55 (51.4)      38 (50.7)      20 (48.8)       .867        12 (42.9)   113 (55.1)   57 (49.1)    .202        105 (55.6)   77 (48.1)    .427        102 (54.0)   80 (50.0)    .705
  Mild                            101 (28.9)     31 (24.6)         32 (29.9)      23 (30.7)      15 (36.6)                   6 (21.4)    55 (26.8)    40 (34.5)                53 (28.0)    48 (30.0)                52 (27.5)    49 (30.6)    
  Moderate                        40 (11.5)      17 (13.5)         13 (12.1)      8 (10.7)       2 (4.9)                     7 (25.0)    22 (10.7)    11 (9.5)                 20 (10.6)    20 (12.5)                23 (12.2)    17 (10.6)    
  Severe                          26 (7.4)       9 (7.1)           7 (6.5)        6 (8.0)        4 (9.8)                     3 (10.7)    15 (7.3)     8 (6.9)                  11 (5.8)     15 (9.4)                 12 (6.3)     14 (8.8)     
  GAD‐7: difficulty functioning                                                                                                                                                                                                                
  Not difficult                   163 (46.7)     61 (48.4)         48 (44.9)      37 (49.3)      17 (41.5)       .562        10 (35.7)   100 (48.8)   53 (45.7)    .269        94 (49.7)    69 (43.1)    .161        92 (48.7)    71 (44.4)    .230
  Somewhat difficult              168 (48.1)     57 (45.2)         55 (51.4)      36 (48.0)      20 (48.8)                   14 (50.0)   96 (46.8)    58 (50.0)                86 (45.5)    82 (51.2)                88 (46.6)    80 (50.0)    
  Very difficult                  15 (4.3)       6 (4.8)           4 (3.7)        1 (1.3)        4 (9.8)                     3 (10.7)    7 (3.4)      5 (4.3)                  6 (3.2)      9 (5.6)                  6 (3.2)      9 (5.6)      
  Extremely difficult             3 (0.9)        2 (1.6)           0 (0.0)        1 (1.3)        0 (0.0)                     1 (3.6)     2 (1.0)      0 (0.0)                  3 (1.6)      0 (0.0)                  3 (1.6)      0 (0.0)      
  IES: distress symptoms                                                                                                                                                                                                                       
  Subclinical                     139 (39.8)     52 (41.3)         33 (30.8)      39 (52.0)      15 (36.6)       .223        10 (35.7)   90 (43.9)    39 (33.6)    .228        88 (46.6)    51 (31.9)    **.027**    89 (47.1)    50 (31.2)    **.013**
  Mild                            114 (32.7)     40 (31.7)         41 (38.3)      16 (21.3)      17 (41.5)                   9 (32.1)    56 (27.3)    49 (42.2)                51 (27.0)    63 (39.4)                50 (26.5)    64 (40.0)    
  Moderate                        73 (20.9)      25 (19.8)         26 (24.3)      16 (21.3)      6 (14.6)                    7 (25.0)    44 (21.5)    22 (19.0)                37 (19.6)    36 (22.5)                37 (19.6)    36 (22.5)    
  Severe                          23 (6.6)       9 (7.1)           7 (6.5)        4 (5.3)        3 (7.3)                     2 (7.1)     15 (7.3)     6 (5.2)                  13 (6.9)     10 (6.2)                 13 (6.9)     10 (6.2)     
  PHQ‐2: depression symptoms                                                                                                                                                                                                                   
  Negative                        312 (89.4)     115 (91.3)        97 (90.7)      63 (84.0)      37 (90.2)       .395        22 (78.6)   187 (91.2)   103 (88.8)   .121        171 (90.5)   141 (88.1)   .592        168 (88.9)   144 (90.0)   .872
  Positive                        37 (10.6)      11 (8.7)          10 (9.3)       12 (16.0)      4 (9.8)                     6 (21.4)    18 (8.8)     13 (11.2)                18 (9.5)     19 (11.9)                21 (11.1)    16 (10.0)    

*Note:* All statistically significant values are marked in bold.

Abbreviations: GAD‐7, 7‐item Generalized Anxiety Disorder Scale; IES, Impact of Event Scale; PHQ‐2, two‐item Patient Health Questionnaire.

The median (IQR) score on the IES for distress was 13.0 (3.0‐27.0). The median (IQR) scores for the two subscores that comprise the distress score were 6.0 (2.0‐13.0) for intrusive symptoms and 6.0 (1.0‐14.0) for avoidance symptoms. Similar to findings in severity of symptoms, female participants had higher scores compared to males (19.0 \[8.0‐31.0\] for females vs 10.0 \[2.0‐22.2\] for males; *P* \< .0005; Table [4](#hed26292-tbl-0004){ref-type="table"}). Those who worked in a state with greater than 20 000 cumulative positive cases had significantly increased scores of distress compared to those who worked in a state with fewer than 20 000 positive cases (17.0 \[5.0‐29.0\] vs 10.0 \[3.0‐27.0\]; *P* = .021), and this was also reflected in the two distress subscores (intrusive and avoidance). Working in a state with greater than 1000 deaths had significantly increased scores of distress compared to working in a state with fewer than 1000 deaths (17.0 \[5.0‐29.0\] vs 10.0 \[2.0‐27.0\]; *P* = .014), and this was also reflected in the two distress subscores. Lastly, geographic region was associated with significant differences in the intrusive subscore of distress (Midwest 5.0 \[1.0‐13.0\], Northwest 8.0 \[3.0‐15.0\], South 3.0 \[1.0‐11.0\], West 6.0 \[1.0‐13.0\]; *P* = .021) (Table [5](#hed26292-tbl-0005){ref-type="table"}).

###### 

Median scores of burnout, anxiety, distress, and depression measurements in total cohort and subgroups (role, sex, and age subgroups)

                                                 Role, median (IQR)   Sex, median (IQR)   Age, median (IQR)                                                                                                                             
  ---------------------------- ----------------- -------------------- ------------------- ------------------- ----------------- ----------------- ------------- ----------------- ----------------- ----------------- ----------------- ----------
  Mini‐Z: burnout symptoms     2.0 (2.0‐2.0)     2.0 (2.0‐3.0)        2.0 (2.0‐2.0)       **\<.0005**         2.0 (2.0‐2.0)     2.0 (2.0‐3.0)     **.004**      2.0 (2.0‐3.0)     2.0 (2.0‐2.0)     2.0 (2.0‐2.0)     2.0 (1.0‐2.0)     **.047**
  GAD‐7: anxiety symptoms      4.0 (2.0‐8.0)     5.0 (2.0‐9.0)        4.0 (2.0‐7.0)       .461                3.0 (1.8‐7.0)     6.0 (3.0‐9.0)     **\<.0005**   5.0 (2.0‐8.0)     4.0 (2.0‐8.0)     4.0 (3.0‐7.2)     4.0 (2.0‐7.0)     .543
  IES: intrusion symptoms      6.0 (2.0‐13.0)    6.0 (2.0‐13.0)       6.0 (1.8‐13.0)      .939                4.0 (1.0‐9.0)     9.0 (3.0‐17.0)    **\<.0005**   6.0 (2.0‐15.0)    6.0 (2.0‐11.8)    6.0 (2.0‐15.0)    6.0 (1.0‐12.0)    .796
  IES: avoidance symptoms      6.0 (1.0‐14.0)    7.0 (2.0‐15.0)       6.0 (1.0‐12.0)      .203                5.0 (0.8‐13.0)    9.0 (3.0‐15.0)    **.001**      8.0 (2.0‐16.8)    6.0 (1.0‐14.0)    5.0 (0.0‐10.0)    7.0 (1.0‐13.0)    .442
  IES: distress symptoms       13.0 (3.0‐27.0)   14.0 (4.0‐29.0)      12.0 (2.8‐26.0)     .486                10.0 (2.0‐22.2)   19.0 (8.0‐31.0)   **\<.0005**   14.0 (4.0‐32.2)   12.5 (3.0‐25.8)   10.0 (2.8‐27.0)   13.0 (3.0‐27.0)   .711
  PHQ‐2: depression symptoms   0.0 (0.0‐2.0)     0.0 (0.0‐2.0)        0.0 (0.0‐2.0)       .895                0.0 (0.0‐1.0)     1.0 (0.0‐2.0)     .098          0.0 (0.0‐2.0)     0.0 (0.0‐1.8)     1.0 (0.0‐2.0)     0.0 (0.0‐2.0)     .993

*Note:* All statistically significant values are marked in bold.

Abbreviations: GAD‐7, 7‐item Generalized Anxiety Disorder Scale; IES, Impact of Event Scale; PHQ‐2, two‐item Patient Health Questionnaire.

###### 

Median scores of burnout, anxiety, distress, and depression measurements in total cohort and subgroups (location, surge status, state COVID‐19‐positive case numbers, and state COVID‐19 deaths)

                                                 Location, median (IQR)   Surge Status, median (IQR)   Cases, median (IQR)   Deaths, median (IQR)                                                                                                                                                              
  ---------------------------- ----------------- ------------------------ ---------------------------- --------------------- ---------------------- ---------- ----------------- ----------------- ----------------- ------ ----------------- ----------------- ---------- ----------------- ----------------- ----------
  Mini‐Z: burnout symptoms     2.0 (2.0‐2.0)     2.0 (2.0‐2.0)            2.0 (2.0‐2.0)                2.0 (2.0‐2.0)         2.0 (2.0‐2.0)          .775       2.0 (2.0‐2.0)     2.0 (2.0‐2.0)     2.0 (2.0‐2.0)     .893   2.0 (2.0‐2.0)     2.0 (2.0‐2.2)     .427       2.0 (2.0‐2.0)     2.0 (2.0‐2.2)     .529
  GAD‐7: anxiety symptoms      4.0 (2.0‐8.0)     4.0 (2.0‐8.8)            4.0 (2.0‐8.0)                4.0 (2.0‐7.0)         5.0 (2.0‐9.0)          .932       5.0 (2.8‐12.2)    4.0 (2.0‐8.0)     5.0 (2.0‐7.0)     .425   4.0 (2.0‐7.0)     5.0 (2.0‐9.0)     .253       4.0 (2.0‐7.0)     4.5 (2.0‐8.0)     .634
  IES: intrusion symptoms      6.0 (2.0‐13.0)    5.0 (1.0‐13.0)           8.0 (3.0‐15.0)               3.0 (1.0‐11.0)        6.0 (1.0‐13.0)         **.021**   6.5 (1.8‐14.8)    6.0 (1.0‐14.0)    7.0 (2.0‐12.0)    .851   5.0 (1.0‐11.0)    7.0 (2.0‐14.3)    **.023**   4.0 (1.0‐11.0)    7.0 (3.0‐15.0)    **.009**
  IES: avoidance symptoms      6.0 (1.0‐14.0)    6.0 (2.0‐13.8)           9.0 (1.0‐15.0)               5.0 (0.5‐12.5)        6.0 (1.0‐13.0)         .290       7.5 (1.8‐18.0)    6.0 (1.0‐13.0)    6.5 (2.0‐13.3)    .468   5.0 (1.0‐12.0)    9.0 (1.0‐15.0)    **.032**   5.0 (1.0‐11.0)    9.0 (1.0‐15.0)    **.019**
  IES: distress symptoms       13.0 (3.0‐27.0)   11.0 (3.2‐27.8)          18.0 (6.0‐29.0)              8.0 (2.0‐26.5)        14.0 (2.0‐25.0)        .082       15.5 (4.5‐29.5)   11.0 (3.0‐28.0)   13.5 (4.0‐25.0)   .678   10.0 (3.0‐27.0)   17.0 (5.0‐29.0)   **.021**   10.0 (2.0‐27.0)   17.0 (5.0‐29.0)   **.014**
  PHQ‐2: depression symptoms   0.0 (0.0‐2.0)     0.0 (0.0‐2.0)            0.0 (0.0‐2.0)                0.0 (0.0‐2.0)         1.0 (0.0‐1.0)          .993       1.0 (0.0‐2.0)     0.0 (0.0‐1.0)     1.0 (0.0‐2.0)     .200   0.0 (0.0‐1.0)     1.0 (0.0‐2.0)     .188       0.0 (0.0‐2.0)     1.0 (0.0‐2.0)     .472

*Note:* All statistically significant values are marked in bold.

Abbreviations: GAD‐7, 7‐item Generalized Anxiety Disorder Scale; IES, Impact of Event Scale; PHQ‐2, two‐item Patient Health Questionnaire.

Multivariable logistic regression analysis also showed that females and physicians working in a state with greater than 20 000 positive cases were associated with increased presence of symptoms of distress (Table [6](#hed26292-tbl-0006){ref-type="table"}). Compared to males, females were more likely to report symptoms of distress (OR 2.68, CI \[1.64‐4.37\]; *P* \< .0005). Compared to physicians working in a state where the number of positive COVID‐19 cases was less than 20 000, those working in a state where the positive case number exceeded 20 000 were more likely to have symptoms of distress (OR 2.01, CI \[1.22‐3.31\]; *P* = 0.006).

###### 

Factors associated with symptoms of burnout, anxiety, distress, and depression following multivariable logistic regression

                                 Participants with symptoms/ Total (%)   Adjusted OR (95%CI)   *P* value     
  ------------------------------ --------------------------------------- --------------------- ------------- -------------
  *Mini‐Z: burnout symptoms*                                                                                 
  Role                                                                                                       
  Resident                       49/165 (29.7)                           1 (Reference)         NA            **.005**
  Attending                      27/184 (14.7)                           0.28 (0.11‐0.68)      **.005**      
  Sex                                                                                                        
  Men                            36/212 (17.0)                           1 (Reference)         NA            **.018**
  Women                          40/137 (29.2)                           1.93 (1.12‐3.32)      **.018**      
  Age                                                                                                        
  26‐30                          27/94 (28.7)                            1 (Reference)         NA            .481
  31‐35                          25/114 (21.9)                           1.14 (0.57‐2.28)      .709          
  36‐40                          10/44 (22.7)                            2.46 (0.76‐7.96)      .131          
  \>40                           14/97 (14.4)                            1.78 (0.57‐5.55)      .317          
  Surge status                                                                                               
  Pre                            6/28 (21.4)                             1 (Reference)         NA            .738
  Surge                          44/205 (21.5)                           0.80 (0.29‐2.25)      .678          
  Post                           26/116 (22.4)                           0.67 (0.22‐2.06)      .482          
  Cases                                                                                                      
  \<20 000                       36/189 (19.0)                           1 (Reference)         NA            .219
  \>20 000                       40/160 (25.0)                           1.44 (0.80‐2.58)      .219          
  *GAD‐7: anxiety symptoms*                                                                                  
  Role                                                                                                       
  Resident                       83/165 (50.3)                           1 (Reference)         NA            .872
  Attending                      84/184 (45.7)                           1.06 (0.53‐2.13)      .872          
  Sex                                                                                                        
  Men                            83/212 (39.2)                           1 (Reference)         NA            **\<.0005**
  Women                          84/137 (61.3)                           2.53 (1.59‐4.02)      **\<.0005**   
  Age                                                                                                        
  26‐30                          52/94 (55.3)                            1 (Reference)         NA            .608
  31‐35                          51/114 (44.7)                           0.66 (0.35‐1.26)      .213          
  36‐40                          21/44 (47.7)                            0.77 (0.29‐2.06)      .605          
  \>40                           43/97 (44.3)                            0.83 (0.34‐2.04)      .681          
  Surge status                                                                                               
  Pre                            16/28 (57.1)                            1 (Reference)         NA            .188
  Surge                          92/205 (44.9)                           0.46 (0.20‐1.07)      .071          
  Post                           59/116 (50.9)                           0.50 (0.20‐1.27)      .146          
  Cases                                                                                                      
  \<20 000                       84/189 (44.4)                           1 (Reference)         NA            .155
  \>20 000                       83/160 (51.9)                           1.42 (0.88‐2.30)      .155          
  *IES: distress symptoms*                                                                                   
  Role                                                                                                       
  Resident                       96/165 (58.2)                           1 (Reference)         NA            .827
  Attending                      114/184 (62.0)                          1.08 (0.53‐2.21)      .827          
  Sex                                                                                                        
  Men                            112/212 (52.8)                          1 (Reference)         NA            **\<.0005**
  Women                          98/137 (71.5)                           2.68 (1.64‐4.37)      **\<.0005**   
  Age                                                                                                        
  26‐30                          56/94 (59.6)                            1 (Reference)         NA            .288
  31‐35                          65/114 (57.0)                           1.01 (0.52‐1.95)      .983          
  36‐40                          25/44 (56.8)                            0.99 (0.36‐2.72)      .990          
  \>40                           64/97 (66.0)                            1.84 (0.72‐4.68)      .204          
  Surge status                                                                                               
  Pre                            18/28 (64.3)                            1 (Reference)         NA            .240
  Surge                          115/205 (56.1)                          0.50 (0.21‐1.19)      .115          
  Post                           77/116 (66.4)                           0.60 (0.23‐1.57)      .298          
  Cases                                                                                                      
  \<20 000                       101/189 (53.4)                          1 (Reference)         NA            **.006**
  \>20 000                       109/160 (68.1)                          2.01 (1.22‐3.31)      **.006**      
  *PHQ‐2: depression symptoms*                                                                               
  Role                                                                                                       
  Resident                       17/165 (10.3)                           1 (Reference)         NA            .496
  Attending                      20/184 (10.9)                           0.65 (0.18‐2.27)      .496          
  Sex                                                                                                        
  Men                            23/212 (10.8)                           1 (Reference)         NA            .945
  Women                          14/137 (10.2)                           1.03 (0.49‐2.17)      .945          
  Age                                                                                                        
  26‐30                          11/94 (11.7)                            1 (Reference)         NA            .110
  31‐35                          7/114 (6.1)                             0.52 (0.17‐1.58)      .251          
  36‐40                          7/44 (15.9)                             2.33 (0.50‐10.87)     .280          
  \>40                           12/97 (12.4)                            1.64 (0.37‐7.40)      .517          
  Surge status                                                                                               
  Pre                            6/28 (21.4)                             1 (Reference)         NA            .055
  Surge                          18/205 (8.8)                            0.23 (0.07‐0.71)      **.011**      
  Post                           13/116 (11.2)                           0.27 (0.08‐0.96)      **.044**      
  Cases                                                                                                      
  \<20 000                       18/189 (9.5)                            1 (Reference)         NA            .272
  \>20 000                       19/160 (11.9)                           1.57 (0.70‐3.49)      .272          

*Note:* The multivariable logistic regression results are found in the "overall" *P* value. The "category" *P* value corresponds to the *P* value for each category compared to the reference. All statistically significant values are marked in bold.

Abbreviations: GAD‐7, 7‐item Generalized Anxiety Disorder Scale; IES, Impact of Event Scale; PHQ‐2, two‐item Patient Health Questionnaire.

3.5. PHQ‐2 Depression Scale scores {#hed26292-sec-0012}
----------------------------------

Thirty‐seven (10.6%) participants were positive on our depression screener. In a clinical setting, patients who screen positive on this depression instrument would then require a more detailed screening to assess depression. The median (IQR) score on the PHQ‐2 for depression for all participants was 0.0 (0.0‐2.0). There were no significant differences in responses to the PHQ‐2 between our subgroups.

4. DISCUSSION {#hed26292-sec-0013}
=============

In this national survey‐based study, we found large proportions of participants to be experiencing symptoms of burnout, anxiety, and distress. Furthermore, we identified demographic risk factors for presence of symptoms, including type of physician, sex, geographic region, and incidence of COVID‐19. Turning attention to physician mental health is of great importance, as these problems have high prevalence in the physician population even prior to this pandemic. Studies conducted prior to the COVID‐19 pandemic have reported prevalence of burnout in all physicians as greater than 50%,[^34^](#hed26292-bib-0034){ref-type="ref"} and prevalence of depressive symptoms in surgeons as around 30%.[^35^](#hed26292-bib-0035){ref-type="ref"} Though studies conflict regarding the exact prevalence of suicide in the U.S. physician population,[^36^](#hed26292-bib-0036){ref-type="ref"} the suicide rate is widely cited as being higher than the general population.[^37^](#hed26292-bib-0037){ref-type="ref"} The increased pressures during the current pandemic have raised concerns for worsening mental health from this baseline.[^38^](#hed26292-bib-0038){ref-type="ref"}, [^39^](#hed26292-bib-0039){ref-type="ref"} Given the route of transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), there is increased concern for otolaryngologists due to the multidisciplinary nature of the field and risk of aerosolization during procedures.[^4^](#hed26292-bib-0004){ref-type="ref"}, [^6^](#hed26292-bib-0006){ref-type="ref"} To our knowledge, this is the only study that has specifically surveyed academic otolaryngologists during a pandemic using standardized metrics of burnout, anxiety, distress, and depression.

Our findings show that 47.9% of participants had symptoms of anxiety, 60.2% had symptoms of distress, 21.8% reported burnout, and 10.6% screened positive for depression symptoms. Out of the four, distress was the most prevalent positive result among our participants. Increased IES scores have correlated with a risk of PTSD, with Coffey et al suggesting a cutoff of 27.[^31^](#hed26292-bib-0031){ref-type="ref"}, [^40^](#hed26292-bib-0040){ref-type="ref"} Also, 27.5% of our participants fall into the moderate and severe ranges, which start at a score of 26. A score of 10 or greater on the GAD‐7 is thought to be a reasonable cutoff point for identifying cases of GAD,[^26^](#hed26292-bib-0026){ref-type="ref"} and 18.9% of our participants scored above that. The PHQ‐2 assesses the degree to which an individual has experienced depressed mood and anhedonia over the past 2 weeks, serving as a screener for depression. It should be emphasized that a positive screening on PHQ‐2 requires further evaluation with the PHQ‐9 to make any conclusions, with 10.6% of our participants warranting additional screening. Overall, the reported symptoms in our study are concerning for the future mental wellbeing of our physicians, particularly regarding distress and anxiety, though further study is needed.

Residents reported increased burnout compared to attendings. This is unsurprising given the nature of their role in the hospital and the increased work hours. Prior studies have revealed significantly elevated levels of burnout in U.S. otolaryngology residents compared to attendings at baseline.[^41^](#hed26292-bib-0041){ref-type="ref"} Importantly, these studies have used the Maslach Burnout Inventory (MBI) as their measure of burnout, which our Mini‐Z Burnout Assessment has been validated against with particularly good correlation for the MBI\'s emotional exhaustion subscale.[^28^](#hed26292-bib-0028){ref-type="ref"} A study by Golub et al reported high emotional exhaustion in 33% of residents, moderate in 29%, and low in 38%, which was strongly associated with increased work hours.[^42^](#hed26292-bib-0042){ref-type="ref"} In our study, 29.7% of residents reported at least "I am definitely burning out and have one or more symptoms of burnout, for example, emotional exhaustion," and 70.3% of residents reported "I enjoy my work. I have no symptoms of burnout" or "I am under stress, and don\'t always have as much energy as I did, but I don\'t feel burned out." Taken together, it is possible that we are in fact seeing a decrease in burnout from baseline in our study. Though residents anecdotally report increased anxiety and stress in response to COVID‐19, they also acknowledge that their work hours are much improved due to the cancellation of elective procedures and limitations on the number of in‐hospital personnel. Thus, in the specific case of burnout, increased time off may have mitigated increased stressors in the workplace for our population.

Given the uneven spread of COVID‐19 throughout the United States, we sought to identify an association between severity of COVID‐19 and our mental health outcome measures. Our findings identified differences in distress based on these variables. Physicians working in states with greater than 20 000 positive cases or 1000 deaths reported increased symptoms of distress compared to those in states with less than 20,00 positive cases or 1000 deaths. When looking specifically at intrusive distress symptoms, separated out from the avoidant symptoms, there was a significant difference by region, with the Northeast having the highest median intrusive distress scores. As the Northeast had a substantially greater number of cases during our study period,[^25^](#hed26292-bib-0025){ref-type="ref"} these participants are more likely to be treating positive patients or potentially being redeployed to other roles, and their stress may be compounded by diminishing PPE. Given the relationship between positive case numbers, death numbers, and region, only the positive case number variable was included in the multivariable analysis, and remained significant for distress.

Female respondents reported significantly higher amounts of burnout, anxiety, and distress. These findings are consistent with those identified in other studies during the current pandemic in China.[^21^](#hed26292-bib-0021){ref-type="ref"}, [^22^](#hed26292-bib-0022){ref-type="ref"} This is also supported by an abundance of literature on a higher prevalence of "internalizing" psychiatric disorders such as anxiety and depression in females compared to males, who have higher prevalence of substance abuse and "externalizing" disorders, including attention‐deficit/hyperactivity disorder, conduct disorder, intermittent explosive disorder, and oppositional defiant disorder.[^43^](#hed26292-bib-0043){ref-type="ref"}, [^44^](#hed26292-bib-0044){ref-type="ref"} However, it is also important to consider the risks of response and measurement bias in these screening tools. These tools rely on symptom‐based reporting, where males may be less likely to report symptoms.[^45^](#hed26292-bib-0045){ref-type="ref"}, [^46^](#hed26292-bib-0046){ref-type="ref"}, [^47^](#hed26292-bib-0047){ref-type="ref"} Furthermore, their symptoms may not fit these standard measurement tools, and their "externalizing" disorders may be masking depression and anxiety.[^46^](#hed26292-bib-0046){ref-type="ref"} For these reasons, it is possible that males may be underdiagnosed by these tools and clinically. Thus, our study may not be fully capturing the state of mental health among males, and therefore it is important to focus efforts on improving mental wellness in all physicians regardless of their gender.

This study has several limitations that are important to consider. Depending on the trajectory of the pandemic, the mental health symptoms of health care workers could intensify or diminish over time. Thus, long‐term psychological implications of this population are worth future investigation. In addition, we did not include a control group and therefore are unable to definitely conclude that these symptoms in health care workers differ from those of the general population or of any other specialty. However, Zhang et al found health care workers mental health scores to be significantly increased compared to nonmedical health care workers during COVID‐19 in China.[^22^](#hed26292-bib-0022){ref-type="ref"} We are also unable to distinguish whether these symptoms are in the setting of preexisting mental health symptoms rather than new symptoms, though free responses to an optional question at the end of the survey suggest that many are experiencing a mental change that they attribute to COVID‐19. In addition, because our survey was emailed to each program director to distribute to their department, we are unable to confirm whether they received this email and/or forwarded it to their department. Given our response rates, we cannot exclude the possibility of a non‐response bias. Providers who received but did not respond to the survey may not have been experiencing any distress, anxiety, burnout, or depression and therefore were not interested in responding. Alternatively, those who received the survey but did not fill it out could have been too overwhelmed to respond.

5. CONCLUSIONS {#hed26292-sec-0014}
==============

The COVID‐19 pandemic presents a challenging position for otolaryngologists, where a calling to serve their communities may be at odds with concern for self and loved ones. Otolaryngologists are particularly at risk due to the aerosolizing nature of their procedures. We found that otolaryngologists are experiencing elevated anxiety and distress. However, the cancellation of elective procedures and measures to limit in‐house personnel may also have provided an increase in time outside of work, mitigating some of the negative effects of the pandemic on mental health. We present here a cross‐sectional analysis of a spectrum of mental health concerns among otolaryngologists\' during this pandemic. Though further studies are needed to capture a longitudinal picture, it is important that institutions start focusing efforts on the mental wellness of their physicians.
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